chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling, Musculoskeletal stiffness, Skin discolouration
Clinical narrative: her elbows looks a little swollen; ELBOW DARKER THAN SKIN COMPLEXION; SHOULDER IS STIFF; shoulder pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of JOINT SWELLING (her elbows looks a little swollen), SKIN DISCOLOURATION (ELBOW DARKER THAN SKIN COMPLEXION), MUSCULOSKELETAL STIFFNESS (SHOULDER IS STIFF) and ARTHRALGIA (shoulder pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced ARTHRALGIA (shoulder pain). On 16-Feb-2021, the patient experienced JOINT SWELLING (her elbows looks a little swollen), SKIN DISCOLOURATION (ELBOW DARKER THAN SKIN COMPLEXION) and MUSCULOSKELETAL STIFFNESS (SHOULDER IS STIFF). At the time of the report, JOINT SWELLING (her elbows looks a little swollen), SKIN DISCOLOURATION (ELBOW DARKER THAN SKIN COMPLEXION), MUSCULOSKELETAL STIFFNESS (SHOULDER IS STIFF) and ARTHRALGIA (shoulder pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported by the reporter. Treatment included ice pack and ibuprofen.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Erythema, Vaccination site swelling
Clinical narrative: 8 red spots; Puffed up near injection site; Stomach pain; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (8 red spots), ABDOMINAL PAIN UPPER (Stomach pain), DIARRHOEA (Diarrhea) and VACCINATION SITE SWELLING (Puffed up near injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included Allergy (chocolate allergy.) and Lactose intolerant. Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain) and DIARRHOEA (Diarrhea). On 16-Feb-2021, the patient experienced ERYTHEMA (8 red spots) and VACCINATION SITE SWELLING (Puffed up near injection site). At the time of the report, ERYTHEMA (8 red spots), ABDOMINAL PAIN UPPER (Stomach pain), DIARRHOEA (Diarrhea) and VACCINATION SITE SWELLING (Puffed up near injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included drink fluids and pepto bismol.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: hot to the touch; itchy; rash; red area on their arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (rash) and VACCINATION SITE ERYTHEMA (red area on their arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (rash) and VACCINATION SITE ERYTHEMA (red area on their arm). At the time of the report, VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (rash) and VACCINATION SITE ERYTHEMA (red area on their arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 67.0
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Fatigue; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection site) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced FATIGUE (Fatigue). On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain at injection site). At the time of the report, FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Dyspepsia
Clinical narrative: Heartburn; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (Heartburn) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced DYSPEPSIA (Heartburn). At the time of the report, DYSPEPSIA (Heartburn) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Headache, Nausea
Clinical narrative: no taste; no smell; headache; nausea; chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), AGEUSIA (no taste), ANOSMIA (no smell), HEADACHE (headache) and NAUSEA (nausea) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Cholesterol, Lung disorder and Heart disorder.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN (Body aches), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills). On 16-Feb-2021, the patient experienced AGEUSIA (no taste) and ANOSMIA (no smell). At the time of the report, PAIN (Body aches), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills) had resolved and AGEUSIA (no taste) and ANOSMIA (no smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included blood pressure, heart, cholesterol and lungs medication. Treatment details were not reported by the reporter.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: no taste; no smell; headache; nausea; chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), AGEUSIA (no taste), ANOSMIA (no smell), HEADACHE (headache) and NAUSEA (nausea) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Cholesterol, Lung disorder and Heart disorder.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN (Body aches), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills). On 16-Feb-2021, the patient experienced AGEUSIA (no taste) and ANOSMIA (no smell). At the time of the report, PAIN (Body aches), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills) had resolved and AGEUSIA (no taste) and ANOSMIA (no smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included blood pressure, heart, cholesterol and lungs medication. Treatment details were not reported by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Dyspnoea, Headache
Clinical narrative: tremor; affected her breathing; dizziness; cramping in legs; chills; bad headaches; temperature of 102; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (cramping in legs), DIZZINESS (dizziness), TREMOR (tremor), DYSPNOEA (affected her breathing) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 28-Jan-2021, the patient experienced MUSCLE SPASMS (cramping in legs), CHILLS (chills), HEADACHE (bad headaches) and PYREXIA (temperature of 102). On 06-Feb-2021, the patient experienced DIZZINESS (dizziness). On an unknown date, the patient experienced TREMOR (tremor) and DYSPNOEA (affected her breathing). At the time of the report, MUSCLE SPASMS (cramping in legs), DIZZINESS (dizziness), TREMOR (tremor), DYSPNOEA (affected her breathing), CHILLS (chills), HEADACHE (bad headaches) and PYREXIA (temperature of 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Body temperature: 102 (Inconclusive) Temperature-102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pyrexia, Tremor
Clinical narrative: tremor; affected her breathing; dizziness; cramping in legs; chills; bad headaches; temperature of 102; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (cramping in legs), DIZZINESS (dizziness), TREMOR (tremor), DYSPNOEA (affected her breathing) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 28-Jan-2021, the patient experienced MUSCLE SPASMS (cramping in legs), CHILLS (chills), HEADACHE (bad headaches) and PYREXIA (temperature of 102). On 06-Feb-2021, the patient experienced DIZZINESS (dizziness). On an unknown date, the patient experienced TREMOR (tremor) and DYSPNOEA (affected her breathing). At the time of the report, MUSCLE SPASMS (cramping in legs), DIZZINESS (dizziness), TREMOR (tremor), DYSPNOEA (affected her breathing), CHILLS (chills), HEADACHE (bad headaches) and PYREXIA (temperature of 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Body temperature: 102 (Inconclusive) Temperature-102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Pain in extremity
Clinical narrative: Sore arm; sick for four days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and ILLNESS (sick for four days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unknown and unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history reported.).   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and ILLNESS (sick for four days). At the time of the report, PAIN IN EXTREMITY (Sore arm) and ILLNESS (sick for four days) outcome was unknown. Not provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment medication was not reported by the reporter.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: Sore arm; Rash in the back that moves to the "bellybutton"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and RASH (Rash in the back that moves to the "bellybutton") in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and RASH (Rash in the back that moves to the "bellybutton"). At the time of the report, PAIN IN EXTREMITY (Sore arm) and RASH (Rash in the back that moves to the "bellybutton") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment medication was not reported by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash pruritic
Clinical narrative: mild itchy rash about 4 inches in diameter; Itchy; Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (mild itchy rash about 4 inches in diameter), PRURITUS (Itchy) and RASH (Rash) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043120A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced RASH PRURITIC (mild itchy rash about 4 inches in diameter), PRURITUS (Itchy) and RASH (Rash). On 03-Feb-2021, RASH PRURITIC (mild itchy rash about 4 inches in diameter), PRURITUS (Itchy) and RASH (Rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-049444 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049444:1st dose
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Axillary mass, Fatigue, Neuralgia, Pyrexia
Clinical narrative: Felt weak; m injection site showed up like a bright red circle,redness; felt tired; weird nerve pain at the injection site,weird nerve pain in my armpit; lump in my armpit; sore arm; Feverish; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of NEURALGIA (weird nerve pain at the injection site,weird nerve pain in my armpit), ASTHENIA (Felt weak), AXILLARY MASS (lump in my armpit), VACCINATION SITE ERYTHEMA (m injection site showed up like a bright red circle,redness) and VACCINATION SITE PAIN (sore arm) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No Reported Medical condition.).    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm) and PYREXIA (Feverish). On 21-Jan-2021, the patient experienced NEURALGIA (weird nerve pain at the injection site,weird nerve pain in my armpit) and AXILLARY MASS (lump in my armpit). On 25-Jan-2021, the patient experienced ASTHENIA (Felt weak), VACCINATION SITE ERYTHEMA (m injection site showed up like a bright red circle,redness) and FATIGUE (felt tired). At the time of the report, NEURALGIA (weird nerve pain at the injection site,weird nerve pain in my armpit), ASTHENIA (Felt weak), AXILLARY MASS (lump in my armpit), VACCINATION SITE ERYTHEMA (m injection site showed up like a bright red circle,redness), VACCINATION SITE PAIN (sore arm), FATIGUE (felt tired) and PYREXIA (Feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: Felt weak; m injection site showed up like a bright red circle,redness; felt tired; weird nerve pain at the injection site,weird nerve pain in my armpit; lump in my armpit; sore arm; Feverish; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of NEURALGIA (weird nerve pain at the injection site,weird nerve pain in my armpit), ASTHENIA (Felt weak), AXILLARY MASS (lump in my armpit), VACCINATION SITE ERYTHEMA (m injection site showed up like a bright red circle,redness) and VACCINATION SITE PAIN (sore arm) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No Reported Medical condition.).    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm) and PYREXIA (Feverish). On 21-Jan-2021, the patient experienced NEURALGIA (weird nerve pain at the injection site,weird nerve pain in my armpit) and AXILLARY MASS (lump in my armpit). On 25-Jan-2021, the patient experienced ASTHENIA (Felt weak), VACCINATION SITE ERYTHEMA (m injection site showed up like a bright red circle,redness) and FATIGUE (felt tired). At the time of the report, NEURALGIA (weird nerve pain at the injection site,weird nerve pain in my armpit), ASTHENIA (Felt weak), AXILLARY MASS (lump in my armpit), VACCINATION SITE ERYTHEMA (m injection site showed up like a bright red circle,redness), VACCINATION SITE PAIN (sore arm), FATIGUE (felt tired) and PYREXIA (Feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Lumpy/Bumpy; Itchy; Redness; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Lumpy/Bumpy), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PAIN (Soreness) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PAIN (Soreness). On 16-Feb-2021, the patient experienced VACCINATION SITE MASS (Lumpy/Bumpy) and VACCINATION SITE PRURITUS (Itchy). At the time of the report, VACCINATION SITE MASS (Lumpy/Bumpy), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site warmth
Clinical narrative: warm to the touch; localized at the injection site and was rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch) and VACCINATION SITE RASH (localized at the injection site and was rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMINS NOS for an unknown indication.    On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch) and VACCINATION SITE RASH (localized at the injection site and was rash). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at a dose of 1 dosage form. On 27-Jan-2021, VACCINATION SITE WARMTH (warm to the touch) and VACCINATION SITE RASH (localized at the injection site and was rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Headache, Paraesthesia, Peripheral swelling
Clinical narrative: Shortness of breath; Joint pain; Headache; electric shock like headache with little tingling in her head; Swelling of the arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling of the arm), DYSPNOEA (Shortness of breath), PARAESTHESIA (electric shock like headache with little tingling in her head), ARTHRALGIA (Joint pain) and HEADACHE (Headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swelling of the arm), PARAESTHESIA (electric shock like headache with little tingling in her head) and HEADACHE (Headache). On 03-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath) and ARTHRALGIA (Joint pain). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (Swelling of the arm), DYSPNOEA (Shortness of breath), PARAESTHESIA (electric shock like headache with little tingling in her head), ARTHRALGIA (Joint pain) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Heart rate irregular, Paraesthesia, Vaccination site pain
Clinical narrative: Chest pain; Pins and needles in the arm of the vaccination; Quivers in the heart and rapid beating sounded like a-fib; Soreness in arm of vaccination; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (Chest pain), PARAESTHESIA (Pins and needles in the arm of the vaccination), HEART RATE IRREGULAR (Quivers in the heart and rapid beating sounded like a-fib) and VACCINATION SITE PAIN (Soreness in arm of vaccination) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cardiac disorder.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain), PARAESTHESIA (Pins and needles in the arm of the vaccination), HEART RATE IRREGULAR (Quivers in the heart and rapid beating sounded like a-fib) and VACCINATION SITE PAIN (Soreness in arm of vaccination). On 05-Feb-2021, PARAESTHESIA (Pins and needles in the arm of the vaccination) had resolved. At the time of the report, CHEST PAIN (Chest pain), HEART RATE IRREGULAR (Quivers in the heart and rapid beating sounded like a-fib) and VACCINATION SITE PAIN (Soreness in arm of vaccination) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 02-Feb-2021, patient had electrocardiogram lab test with normal range. Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Gestational diabetes, Maternal exposure during pregnancy, Pregnancy test, Scan
Clinical narrative: exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a patient (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Chronic UTI (Improved recently) in 1990 and Pre-eclampsia (Sudden onset pre-eclampsia; no complications with infant). Concurrent medical conditions included Drug allergy (Sulfa medications) and Alcohol use (1 drink a week). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for Pre-eclampsia, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 13-Feb-2021 at 8:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 17-Jun-2020 and the estimated date of delivery was 30-Mar-2021. On 13-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fourth week of the pregnancy.  On 13-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jul-2020, Pregnancy test: positive (Positive) positive. In November 2020, Scan: normal (normal) normal. In January 2021, Blood test normal: normal (normal) normal. In January 2021, Gestational diabetes: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. Estimated date of conception: 07 Jul 2020 Previous pregnancy on 11 AP 2019 resulted into Sudden onset pre-eclampsia; no complications with infant.
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: sneezing and just continues to sneeze; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (sneezing and just continues to sneeze) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced SNEEZING (sneezing and just continues to sneeze). At the time of the report, SNEEZING (sneezing and just continues to sneeze) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Pain in extremity
Clinical narrative: stomach sick; Left arm hurting; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach sick) and PAIN IN EXTREMITY (Left arm hurting) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L2OA) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cardiac arrest.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (Left arm hurting). On 17-Jan-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach sick). On 18-Jan-2021, ABDOMINAL DISCOMFORT (stomach sick) and PAIN IN EXTREMITY (Left arm hurting) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications Blood pressure medication, cardiac medication. Treatment details were not provided.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive for covid after receiving the vaccine; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Tested positive for covid after receiving the vaccine) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concomitant products included CALCIUM, VITAMIN C [ASCORBIC ACID], COLECALCIFEROL (VITAMINE D) and Multivitamin (Mulltivitamin) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 20-Jan-2021, the patient experienced COVID-19 (Tested positive for covid after receiving the vaccine). At the time of the report, COVID-19 (Tested positive for covid after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment information was not provided .
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Inflammation, Pain
Clinical narrative: Mild Achiness; Inflammation; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Mild Achiness) and INFLAMMATION (Inflammation) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PAIN (Mild Achiness) and INFLAMMATION (Inflammation). At the time of the report, PAIN (Mild Achiness) and INFLAMMATION (Inflammation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Headache, Pyrexia, Swelling
Clinical narrative: Redness in her arm; Swelling in her arm; Fever; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness in her arm), SWELLING (Swelling in her arm), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced SWELLING (Swelling in her arm), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). On 16-Feb-2021, the patient experienced ERYTHEMA (Redness in her arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, ERYTHEMA (Redness in her arm), SWELLING (Swelling in her arm), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dizziness, Flushing, Headache
Clinical narrative: Arm started to swell; Really flush; felt very weak; Not able to eat; fast heart rate; dizzy/like was going to faint; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm started to swell), FLUSHING (Really flush), ASTHENIA (felt very weak), DECREASED APPETITE (Not able to eat) and HEART RATE INCREASED (fast heart rate) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shingles in December 2020. Previously administered products included for an unreported indication: VALACYCLOVIR HCL until 17-Jan-2021.    On 14-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm started to swell), FLUSHING (Really flush), ASTHENIA (felt very weak), DECREASED APPETITE (Not able to eat), HEART RATE INCREASED (fast heart rate), DIZZINESS (dizzy/like was going to faint) and NAUSEA (nausea). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, PERIPHERAL SWELLING (Arm started to swell), FLUSHING (Really flush), ASTHENIA (felt very weak), DECREASED APPETITE (Not able to eat), HEART RATE INCREASED (fast heart rate), DIZZINESS (dizzy/like was going to faint), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, Herpes zoster: positive RESOLVED.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Herpes zoster, Nausea, Peripheral swelling
Clinical narrative: Arm started to swell; Really flush; felt very weak; Not able to eat; fast heart rate; dizzy/like was going to faint; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm started to swell), FLUSHING (Really flush), ASTHENIA (felt very weak), DECREASED APPETITE (Not able to eat) and HEART RATE INCREASED (fast heart rate) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shingles in December 2020. Previously administered products included for an unreported indication: VALACYCLOVIR HCL until 17-Jan-2021.    On 14-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm started to swell), FLUSHING (Really flush), ASTHENIA (felt very weak), DECREASED APPETITE (Not able to eat), HEART RATE INCREASED (fast heart rate), DIZZINESS (dizzy/like was going to faint) and NAUSEA (nausea). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, PERIPHERAL SWELLING (Arm started to swell), FLUSHING (Really flush), ASTHENIA (felt very weak), DECREASED APPETITE (Not able to eat), HEART RATE INCREASED (fast heart rate), DIZZINESS (dizzy/like was going to faint), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, Herpes zoster: positive RESOLVED.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: site of injection is itching; site of injection feels warm to the touch; site of injection has red mark; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (site of injection is itching), VACCINATION SITE INDURATION (site of injection feels warm to the touch) and VACCINATION SITE ERYTHEMA (site of injection has red mark) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (site of injection is itching), VACCINATION SITE INDURATION (site of injection feels warm to the touch) and VACCINATION SITE ERYTHEMA (site of injection has red mark). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (site of injection is itching), VACCINATION SITE INDURATION (site of injection feels warm to the touch) and VACCINATION SITE ERYTHEMA (site of injection has red mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.   No treatment information reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: only reaction from her first dose was sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (only reaction from her first dose was sore arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0391L20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included Autoimmune disorder (She called to inform us at Moderna that she had auto immune disorder and she is taking biological medication agent) and Rheumatoid arthritis. Previously administered products included for an unreported indication: KEVZARA since an unknown date. Concomitant products included SARILUMAB for Autoimmune disorder.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (only reaction from her first dose was sore arm). At the time of the report, PAIN IN EXTREMITY (only reaction from her first dose was sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information provided.    This case was linked to MOD-2021-041497 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Pain in extremity
Clinical narrative: intense right upper quadrant pain; horrible arm pain; This spontaneous case was reported by a nurse and describes the occurrence of ABDOMINAL PAIN UPPER (intense right upper quadrant pain) and PAIN IN EXTREMITY (horrible arm pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (intense right upper quadrant pain) and PAIN IN EXTREMITY (horrible arm pain). On 13-Jan-2021, ABDOMINAL PAIN UPPER (intense right upper quadrant pain) and PAIN IN EXTREMITY (horrible arm pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Insomnia
Clinical narrative: INSOMNIA; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (INSOMNIA) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced INSOMNIA (INSOMNIA). At the time of the report, INSOMNIA (INSOMNIA) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported.    No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever after vaccination) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever after vaccination). At the time of the report, PYREXIA (Fever after vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow-up received on 16-Apr-2021: Event outcome was updated. The patient told that she was doing fine.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Bone pain, Chills, Headache
Clinical narrative: bone pain; chills; headache; 99.7 temperature; sleepy; weakness; knee pain; This spontaneous case was reported by a consumer and describes the occurrence of   in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included COLECALCIFEROL, MENAQUINONE-7, PHYTOMENADIONE, RETINOL PALMITATE, TOCOPHEROL, TOCOTRIENOLS NOS (VITAMIN D COMPLEX).    On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Somnolence
Clinical narrative: bone pain; chills; headache; 99.7 temperature; sleepy; weakness; knee pain; This spontaneous case was reported by a consumer and describes the occurrence of   in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included COLECALCIFEROL, MENAQUINONE-7, PHYTOMENADIONE, RETINOL PALMITATE, TOCOPHEROL, TOCOTRIENOLS NOS (VITAMIN D COMPLEX).    On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.